Rezultati pretraživanja
  1. prije 19 sati

    And not only did we play short on budget day, we played the reversal also with precision. See where Nifty reversed!

  2. prije 14 sati

    Prof Karl Peggs gives an overview of -T and the exciting research programme in

    Prikaži ovu nit
  3. 30. sij

    📄 Here's the intro post of our new blog series focusing on Advanced Therapy Medicinal Products (ATMPs): regulation, reimbursement, manufacturing, clinical studies, ... 🗂️ Read blogpost =>

  4. prije 22 sata

    French Sécurité Sociale denies exception for early reimbursement of Zynteglo* (French). Final decision will be taken later, following the normal (and lengthy) procedure. This contrasts with previous decision for Yescarta and Kymriah.

  5. For a first idea how to get an development from the laboratory to the patient, has prepared a brilliant infosheet explaining the most important terms on one page

  6. Drawing what self care looks like to them! Good job students today! – mjesto: Port Houston Elementary

  7. prije 18 sati

    Pleased to be attending the Cell and Gene Therapy Innovation Summit in Berlin today. , ,

  8. . releases guidance documents and updates its policies on product development and with the industry sector booming.

  9. prije 14 sati

    Déjeuner débat du Cercle & Santé sur le thème "Pour un système universel de au " autour de

  10. prije 16 sati

    Le Journal Officiel vient de publier les indicateurs nécessaires au calcul des taux de cotisation pour l’année 2020. Les années se succèdent et la hausse des coûts moyens ne se dément pas.

  11. prije 17 sati

    Excellent presentation from on Intellia Therapeutics approach for genome editing. , ,

  12. prije 19 sati

    [Infographic] We can’t believe that the first month of 2020 is already over! Reflecting back, 2019 was a great year for RoslinCT. Looking ahead, 2020 is already gearing up to be even better!

  13. 4. velj

    Da hat anscheinend jemand bessere Vorschläge für Evidenz-basierte klinische -Studien zu seltenen, lebensbedrohlichen Erkrankungen im Petto? 🤔

    Prikaži ovu nit
  14. 4. velj

    This blog looks at some alternative methods to which could drastically speed up sample preparation

  15. 4. velj

    Chaque année, l’Assurance Maladie publie dans son rapport les dernières tendances en matière de risques professionnels. Découvrez dans notre infographie, les chiffres clés relatifs aux , avec un focus sur les et la lombalgie.

  16. 3. velj

    students from practiced journaling today. Don’t talk about self-care, practice it.

  17. 3. velj
  18. 3. velj

    SFL’s CEO is presenting on “Regulating tomorrow's : promoting and while maintaining consumer and ” at the Swiss HLG2020 Conference.

  19. 3. velj

    Procédure de reconnaissance des . Depuis le 1er décembre, plusieurs aspects des procédures de reconnaissance des et ont évolué. Retrouvez dans ces 2 infographies les grands points à retenir. 👉

  20. The regulatory hub for is the CAT, the Committee for of the European Medicines Agency's ():

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.